We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Antioxidants Treat Smith-Lemli-Opitz Syndrome

News   Feb 05, 2018 | By Ellen Goldbaum for University at Buffalo

 
Evidenced-Based Antioxidant Therapy Prevents Vision Loss Caused by Smith-Lemli-Opitz Syndrome

Light microscopy images of retinas from animal model of Smith-Lemli-Opitz Syndrome (SLOS). Treatment with antioxidant combination therapy (right) preserved normal retinal structure and prevented degeneration and death of photoreceptor cells (rods and cones). Credit: Steven Fliesler

 
 
 

RELATED ARTICLES

A Potential Role for Sperm in Repeat Miscarriages

News

In a new study, researchers analyze the potential role that sperm DNA damage may have in recurrent pregnancy loss.

READ MORE

Nanotechnology Approach for Treating Aggressive Breast Cancer

News

Triple negative breast cancer has no currently approved targeted therapies for treatment. Utilizing nanotechnology, a research group have developed a method that targets specific genes in triple negative breast cancer, killing cancerous cells.

READ MORE

Team Sport Participation Linked to Brain Changes in Children

News

Adult depression has long been associated with shrinkage of the hippocampus, a brain region that plays an important role in memory and response to stress. Now, new research has linked participation in team sports to larger hippocampal volumes in children and less depression in boys ages 9 to 11.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE